Mealey's (May 5, 2020, 1:45 PM EDT) -- ALEXANDRIA, Va. — Efforts by Apotex Inc. and Apotex Corp. (Apotex, collectively) to persuade the Patent Trial and Appeal Board to revisit its 2018 decision denying institution of inter partes review (IPR) were unsuccessful on April 30, when the board denied rehearing (Apotex Inc., et al. v. Celgene Corp., No. IPR2018-00685, PTAB)....